XML 106 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under the 2021 Plan and 2018 Plan is as follows (in thousands, except share and per share data and years):

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

Weighted-

 

 

average remaining

 

 

Aggregate

 

 

 

 

 

 

average

 

 

contractual

 

 

intrinsic

 

 

 

Shares

 

 

exercise price

 

 

term (years)

 

 

value

 

Outstanding at December 31, 2021

 

 

13,818,212

 

 

$

3.87

 

 

 

8.82

 

 

$

163,264

 

Granted

 

 

4,272,046

 

 

 

11.59

 

 

 

 

 

 

 

Exercised

 

 

(357,244

)

 

 

1.29

 

 

 

 

 

 

 

Canceled

 

 

(420,311

)

 

 

5.11

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

 

17,312,703

 

 

$

5.79

 

 

 

8.88

 

 

$

67,194

 

Options exercisable at March 31, 2022

 

 

4,201,565

 

 

$

2.24

 

 

 

8.18

 

 

$

26,979

 

 

Assumptions used to Determine Fair Value of Stock Option Grants

The assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:

 

 

 

Three Months Ended March 31,

 

 

2022

 

2021

Risk-free interest rate

 

1.46%-1.74%

 

0.59%-1.01%

Expected volatility

 

85.86%-85.99%

 

83.4%-83.9%

Expected term (in years)

 

5.99-6.08

 

6.08

Expected dividend yield

 

--%

 

--%

Summary of Restricted Stock Activity

The summary of the Company’s restricted stock activity during the three months ended March 31, 2022 is as follows:

 

 

 

Number of

 

 

Weighted-

 

 

 

restricted

 

 

average

 

 

 

stock shares

 

 

grant date

 

 

 

outstanding

 

 

fair value

 

Nonvested at December 31, 2021

 

 

212,941

 

 

$

0.001

 

Vested

 

 

(86,198

)

 

 

0.001

 

Forfeited

 

 

(6,945

)

 

 

0.001

 

Nonvested at March 31, 2022

 

 

119,798

 

 

$

0.001

 

Schedule of Stock-based Compensation Expense

The allocation of stock-based compensation for all stock awards was as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Research and development

 

$

2,732

 

 

$

491

 

General and administrative

 

 

1,710

 

 

 

304

 

Total

 

$

4,442

 

 

$

795

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following as of March 31, 2022 and December 31, 2021:

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Stock options issued and outstanding

 

 

17,312,703

 

 

 

13,818,212

 

Awards available for future grant

 

 

16,923,767

 

 

 

14,699,430

 

Shares available for purchase under the ESPP

 

 

1,168,013

 

 

 

1,168,013

 

Total

 

 

35,404,483

 

 

 

29,685,655